27 March - 29 March 2019

36th SCI Process Development Symposium

Organised by:

SCI's Fine Chemicals Group

Cambridge, UK

Registration Closed

This event is no longer available for registration.


Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering.

The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies.
The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state of the art process development. As an established and well attended meeting, the process development symposium offers an excellent opportunity for networking between like-minded process scientists of all levels of experience and from all areas of the chemical industry.

Wednesday 27 March 2019

11.00 Registration and refreshments
12.15 Lunch
  CHAIR: David Pascoe, GlaxoSmithKline, UK
13.25 Opening remarks

Approaches to Synthesis and Scale-up of a Wee-1 Kinase Inhibitor
Dr Thomas Langer, AstraZeneca, UK


Novel industrial applications for electrochemistry - expecting the unexpected
Dr Patrik Stenner, Evonik, Germany


Homogeneous catalysis research @ BASF: A new Pd-catalyzed low pressure carbonylation
Dr Mathias Schelwies, BASF, Germany

15.30 Refreshment break and exhibition
  CHAIR: Stella James, Bionow, UK

New catalytic strategies for complex alkyl amine synthesis
Prof Matt Gaunt, University of Cambridge


MK-8591 — development of an enzymatic cascade for commercial manufacture
Dr Becky Ruck, MSD, USA

17.30 Closing remarks
17.45 Wine reception sponsored by Chiralquest
19.00 Dinner for residents


Thursday 28 March 2019

  CHAIR: David Lathbury, Astute Chemical Development Consulting Ltd, UK

Total synthesis of polycyclic natural products
Prof Ang Li, SIOC, China


Some process development aspects of industrial fluorine chemistry
Dr Christoph Taeschler, Lonza AG, Switzerland

10.20 Refreshment break and exhibition
  CHAIR: Rob Walton, Pfizer, UK

Authorisation: Aprotic solvents and the pharmaceutical industry
Dr Tom Griffiths, ERM, UK


Scaling up Photoredox Reactions via Flow Chemistry
Dr Kaid Harper, Abbvie, USA

12.10 Lunch and exhibition

Leveraging integrated technology platform and intimate partnership in innovative API development and manufacturing
Dr Gangli Gong, STA Pharmaceutical Co Ltd


Flow chemistry, an enabling technology in Pharma
Dr Francesco Venturoni, Novartis, Switzerland


Impurity evaluation — current areas of interest and future challenges
Dr Andy Teasdale, AstraZeneca, UK

15.10 Refreshment break and exhibition
  CHAIR: Alan Robinson, Syngenta, Switzerland

Making a difference to malaria sufferers throughout the world – Process development of Tafenoquine Succinate
Mr Andrew Kennedy, GlaxoSmithKline, UK

16.20 Process Chemistry Award winner 2019: Mechanistic investigations driving catalyst development: solving reactions of industrial relevance through academic curiosity
Prof Ian Fairlamb, University of York, UK
17.20 Closing remarks
17.30 Wine reception sponsored by Johnson Matthey
19.00 Conference dinner


Friday 29 March 2019

  CHAIR: Louis Diorazio, AstraZeneca, UK

ERK Inhibitor LY3214996 Development and Route Selection (ERK = extracellular signal-regulated kinases)
Dr Nick Magnus, Lilly, USA


ReactIR and FBRM in manufacturing process development
Dr Hazmi Tajuddin, Syngenta, UK

10.20 Refreshment break and exhibition

Scaling Up of Continuous Flow Processes for Active Pharmaceutical
Ingredients (APIs) linking the Manufacturing of APIs to their Formulation

Dr Peter Poechlauer, Patheon, Austria


The JAK3 Inhibitor PF-06651600 – Commercial Route Identification
Dr David Daniels, Pfizer Ltd, UK

12.10 Conference close

Venue and Contact


Storey’s Way

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Early bird fees before Friday 1 February  2019

£375 SCI Member
£260 SCI Subsidised Member
£420 Non-Member


Standard fees after Friday 1 February 2019

£495 SCI Member
£290 SCI Subsidised Member
£550 Non-Member


Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

CPR Accredition Logo


Additional Info


Accommodation can be booked for delegates at the college in single study ensuite or standard bedrooms. Bedrooms will be allocated on a first come, first served basis.
The accommodation package is for 2 nights - Wednesday 27 and Thursday 28 March and includes full English or Continental breakfast. Rooms must be vacated by 10.00am on the day of departure. To make a reservation, please click here.

Please note: Bedrooms at the college will be available from 14.00 on the day of arrival. Those not wishing to stay in college accommodation can book accommodation directly through www.visitcambridge.org.

Exhibition and Sponsorship

An exhibition will run alongside the conference during refreshment breaks, for companies and related organisations who may wish to exhibit. For further information and prices please email jacqui.maguire@soci.org

Organising Committee

  • Dave Lathbury, SCI/Astute Chemical Development Ltd
  • David Pascoe, SCI/GlaxoSmithKline
  • Robert Walton, SCI/Pfizer
  • Louis Diorazio, SCI/AstraZeneca
  • Stella James, SCI/Bionow
  • Alan Robinson, SCI/Syngenta
  • Steven Oliver, Merck Sharp & Dohme
  • Andy Wells, Charnwood Technical Consulting Ltd

Become an SCI Member to receive events discounts

Join SCI